Progressive Casualty Insurance v. Liberty Mutual Liberty Mutual Insurance

625 F. App'x 552
CourtCourt of Appeals for the Federal Circuit
DecidedAugust 24, 2015
Docket2014-1466, 2014-1538, 2014-1549, 2014-1586, 2014-1636, 2014-1637, 2014-1639, 2014-1656
StatusUnpublished
Cited by2 cases

This text of 625 F. App'x 552 (Progressive Casualty Insurance v. Liberty Mutual Liberty Mutual Insurance) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Progressive Casualty Insurance v. Liberty Mutual Liberty Mutual Insurance, 625 F. App'x 552 (Fed. Cir. 2015).

Opinion

*555 TARANTO, Circuit Judge.

Liberty Mutual Insurance Company initiated seven overlapping proceedings against Progressive Casualty Insurance Company in the Patent and Trademark Office, challenging many claims of several of Progressive’s insurance-related patents under the statutory program for review of “covered business method” patents. See GTNX, Inc. v. INTTRA, Inc., 789 F.3d 1309, 1310 (Fed.Cir.2015) (describing transitional program for review of such patents under 35 U.S.C. §§ 321-329, pursuant to the Leahy-Smith America Invents Act, Pub.L. No. 112-29, § 18(a)(1), 125 Stat. 284, 329-31 (2011)). We now have before us Progressive’s appeals from the Patent Trial and Appeal Board’s final written decisions that many claims are invalid over prior art. See 35 U.S.C. §§ 328, 329. We affirm. We need not address Liberty’s cross-appeal in one proceeding, because that cross-appeal concerns claims held invalid in another proceeding whose result we affirm.

The claims at issue come from five patents: (1) claims 1-20 of U.S. Patent No. 8,140,358; (2) claims 1-78 of U.S. Patent No. 8,090,598; (3) claims 1 and 3-18 of U.S. Patent No. 6,064,970; (4) claims 1-46 of U.S. Patent No. 7,124,088; and (5) claims 1-9 and. 13-59 of U.S. Patent No. 7,877,269. The challenged claims of the '358, '598, and '970 patents relate to. pricing automobile insurance based on vehicle use, such as the number of sudden stops over a given period. The challenged claims of the '088 and '269 patents relate to adjusting insurance policies online.

For oral argument, we organized the appeals from the Board’s seven decisions into four (single-case or multi-case) groups. We follow that grouping here and address a subset of the many issues raised by the parties. We have jurisdiction under 28 U.S.C. § 1295(a)(4)(A).

A

The first group of appeals consists of Progressive’s 141636 .and 14-1639 appeals and Liberty’s 14-1637 cross-appeal. The appeals are from two .final written decisions of the Board that address the '358 patent. In CBM 20123, 2014 WL 651401 (Feb. 11, 2014), the Board invalidated all claims but 1, 19,. and 20 for obviousness. In CBM 2013-9, 2014 WL 651402 (Feb. 11, 2014), the Board invalidated all claims of the '358 patent for obviousness. As Progressive and Liberty agreed at oral argument, Oral Arg. (14-1336, -1337, -1339) at Í3:30-14:40, the decision in CBM 2012-3 need not be addressed if we affirm the decision in CBM 2012-9 — which we do.

As a preliminary matter, we reject Progressive’s' argumént that, under 35 U.S.C.' § 325(e)(1), the Board was es-topped from entering its CBM 2013-9 decision.' Section 325(e)(1) provides:

-Proceedings before the office. — The petitioner in a post-grant review of a claim in a patent under this chapter that results in a final written decision under section 328(a), or the real party in interest or privy of the petitioner, may not request or maintain a proceeding before , .the Office with respect to that claim on any ground that the petitioner raised or reasonably could have raised during that post-grant review.

Progressive argues that § 325(e)(1) bars the Board’s entry .of its CBM 2013-9 decision because the Board posted that decision to its electronic docketing system just over an hour after, but the same day as, it posted the CBM 2012-3 decision.

Thére are two problems with Progressive’s contention. First: § 325(e)(1) by its terms does not prohibit- the Board from reaching decisions. It limits only certain (requesting or maintaining) actions by a *556 petitioner. Nothing- in the provision, or chapter 32 more generally, equates that limitation on á petitioner with Board authority to enter a decision. Cf § 327(a) (Board may enter decision even aftér petitioner settles and drops out of the proceeding).

Second: ' § 325(e)(1) does not say when a final decision begins to have estoppel effect (on the petitioner). Here, the Board' stated in ’its two decisions that they were being entered “concurrently.” CBM 2012-3, 2014 WL 651401, at *2; CBM 2013-9, 2014 WL 651402, at *1. The Board previously agreed to the parties’ joint request to “synchronize the timelines in both trials” because the reviews involved the same parties, the same patent, and overlapping prior-art references. A8387 (14-1639 appeal). We see nothing in the statute (or any regulation or other source) that forecloses the Board’s treatment of the two same-day decisions as simultaneous and therefore outside § 325(e)(l)’s scope, regardless of the precise times of posting on an electronic docketing system. See also §§ 325(d), 326(a)(4) (conferring authority on the PTO to decide how to deal with multiple related proceedings).

On the merits, we conclude that the Board did not err in invalidating all' of the '358 patent’s claims in CBM 2013-9. We address two of Progressive’s challenges to that ruling — one procedural, the other substantive.

Progressive argues that the Board committed a procedural error by relying, in its final written decision, on a portion of Kosaka, a published Japanése patent application (Jap.Pub.App.H4-182868), that neither Liberty’s petition nor the Board’s institution decision had relied on. Kosaka describes a device that determines insurance premiums by evaluating risk in moving bodies. It describes an embodiment that uses fuzzy logic, and the Board, in its institution decision, pointed to Kosaka’s fuzzy-logic processor and memory as disclosing certain limitations of Progressive’s patent claims. Progressive responded in its patent-owner response that a relevant skilled artisan would neither have experience with nor understand fuzzy logic. The Board rejected the argument in its final written decision, relying, in part on Kosa-ka’s statement that “‘determination [of risk,evaluation values] may be carried out without using fuzzy logic’” by using a “ ‘common insurance table’ ” instead. A5036 (quoting A5162) (14-1639 appeal). Neither Liberty’s petition nor the Board’s institution decision had pointed-to the insurance-table, passage of Kosaka; it was raised for the first time, as teaching claim limitations, in Liberty’s postiinstitution reply brief — after Progressive no longer had a full opportunity to respond to it with evidence.

' Liberty, along with the Director of the PTO, argues that the Board’s reliance on the previously unmentioned passage in Ko-saka was not a “new ground of rejection” because that label applies only in examination and reexamination. See 37 C.F.R. § 41;50(b); 37 C.F.R, § 41.77(b). But the Administrative Procedure Act imposes its own similar obligations on Board actions, including- in covered business method reviews. For example, 5 U.S.C. § 554(b)(3) requires that “[p]ersons entitled to notice of an agency hearing shall be timely informed of ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Paice LLC v. Ford Motor Company
881 F.3d 894 (Federal Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
625 F. App'x 552, Counsel Stack Legal Research, https://law.counselstack.com/opinion/progressive-casualty-insurance-v-liberty-mutual-liberty-mutual-insurance-cafc-2015.